Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug Utilization"" wg kryterium: Temat


Tytuł :
Thalidomide control and use: are these appropriate to extend the use and mitigate the risk of teratogenicity in Brazil?
Autorzy :
Campos FT; Universidade Federal de Minas Gerais. Av. Pres. Antônio Carlos 6627, Pampulha. 31270-901 Belo Horizonte MG Brasil. .; Fundação Ezequiel Dias. Belo Horizonte MG Brasil.
Santos RMMD; Fundação Ezequiel Dias. Belo Horizonte MG Brasil.
Costa JP; Secretaria Estadual de Saúde de Minas Gerais. Belo Horizonte MG Brasil.
Pádua CAM; Universidade Federal de Minas Gerais. Av. Pres. Antônio Carlos 6627, Pampulha. 31270-901 Belo Horizonte MG Brasil. .
Pokaż więcej
Transliterated Title :
Controle e utilização da talidomida: adequados à ampliação do uso e mitigação do risco de teratogenicidade no Brasil?
Źródło :
Ciencia & saude coletiva [Cien Saude Colet] 2021 Sep; Vol. 26 (9), pp. 4233-4242. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Utilization*
Thalidomide*/adverse effects
Brazil ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases.
Autorzy :
Antonazzo IC; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Fornari C; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Paoletti O; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Bartolini C; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Conti S; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Cortesi PA; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Mantovani LG; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Gini R; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Mazzaglia G; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2021 Aug; Vol. 121 (8), pp. 1115-1118. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/epidemiology
Drug Utilization*
Anticoagulants/*therapeutic use
Adult ; Cardiovascular Diseases/drug therapy ; Disease Outbreaks ; Health Services Accessibility ; Humans
Opinia redakcyjna
Tytuł :
Non-antibiotic medication use in an Indonesian community cohort 0-18 months of age.
Autorzy :
At Thobari J; Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Satria CD; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Ridora Y; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Watts E; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Handley A; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Medicines Development for Global Health, Melbourne, Victoria, Australia.
Standish J; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Bachtiar NS; PT Bio Farma, Bandung, West Java, Indonesia.
Buttery JP; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Department of Paediatrics, Monash University, Clayton, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.; Department of Infection and Immunity, Monash Children's Hospital, Clayton, Victoria, Australia.
Soenarto Y; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Bines JE; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 18; Vol. 15 (11), pp. e0242410. Date of Electronic Publication: 2020 Nov 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Therapy/*trends
Drug Utilization/*statistics & numerical data
Drug Utilization/*trends
Analgesics ; Antipyretics ; Drug Therapy/statistics & numerical data ; Drug Utilization Review/methods ; Female ; Histamine Antagonists ; Humans ; Indonesia/epidemiology ; Infant ; Infant, Newborn ; Male ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł :
Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.
Autorzy :
Shakeri A; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Gomes T; Unity Health Toronto, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Suda K; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Tadrous M; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 May; Vol. 128 (5), pp. 649-651. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/drug therapy
COVID-19*/epidemiology
Chronic Disease*/drug therapy
Chronic Disease*/epidemiology
Drug Utilization*/statistics & numerical data
Drug Utilization*/trends
Pharmaceutical Preparations*/classification
Pharmaceutical Preparations*/supply & distribution
Pharmacoepidemiology*/methods
Pharmacoepidemiology*/trends
Strategic Stockpile*/methods
Strategic Stockpile*/statistics & numerical data
Canada/epidemiology ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; Forecasting ; Humans ; Medication Adherence/statistics & numerical data ; Practice Patterns, Physicians' ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Off-label postpartum use of domperidone in Canada: a multidatabase cohort study.
Autorzy :
Moriello C; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Paterson JM; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Reynier P; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Dahl M; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Aibibula W; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Fisher A; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Gamble JM; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Kuo IF; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Ronksley PE; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Winquist B; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Filion KB; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que. .
Pokaż więcej
Corporate Authors :
Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
Źródło :
CMAJ open [CMAJ Open] 2021 May 14; Vol. 9 (2), pp. E500-E509. Date of Electronic Publication: 2021 May 14 (Print Publication: 2021).
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Death, Sudden, Cardiac*/epidemiology
Death, Sudden, Cardiac*/etiology
Death, Sudden, Cardiac*/prevention & control
Drug Utilization*/statistics & numerical data
Drug Utilization*/trends
Postpartum Period*
Tachycardia, Ventricular*/chemically induced
Tachycardia, Ventricular*/diagnosis
Tachycardia, Ventricular*/epidemiology
Domperidone/*adverse effects
Lactation Disorders/*drug therapy
Off-Label Use/*statistics & numerical data
Adult ; Antiemetics/adverse effects ; Canada/epidemiology ; Female ; Humans ; Interrupted Time Series Analysis ; Lactation/drug effects ; Practice Patterns, Physicians'/statistics & numerical data ; Pregnancy ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997-2017.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Hoxha A; Sciensano, Brussels, Belgium.
Quinten C; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Ayele GM; Allergan Plc, 5 Giralda Farms, Madison NJ, USA.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Muller A; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Heuer O; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Monnet DL; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii68-ii78.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Europe ; European Union ; Humans
Czasopismo naukowe
Tytuł :
Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Monnet DL; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii2-ii6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Data Collection ; Europe ; European Union ; Humans
Czasopismo naukowe
Tytuł :
Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Monnet DL; Disease Programmes, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Weist K; Disease Programmes, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii79-ii85.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Europe ; Humans
Czasopismo naukowe
Tytuł :
Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care.
Autorzy :
Peñalva G; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocio, Spanish National Research Council, University of Seville, Seville, Spain.
Benavente RS; Promotion of Rational Use of Medicines Service, Sub-Directorate of Pharmacy and Provisions, Directorate General of Healthcare and Outcomes in Health, Andalusian Healthcare Service, Seville, Spain.
Pérez-Moreno MA; Clinical Unit of Pharmacy, University Hospital Virgen del Rocio, Institute of Biomedicine of Seville, Seville, Spain.
Pérez-Pacheco MD; Primary Care Pharmacy Service, Clinical Unit of Pharmacy, Health Management Area of Jerez, Costa Noroeste and Sierra de Cadiz, Jerez de la Frontera, Spain.
Pérez-Milena A; Primary Healthcare Centre El Valle, Jaen, Spain.
Murcia J; Primary Care Pediatrics Coordination, Clinical Management Unit Bulevar, Health District of Jaen, Spain.
Cisneros JM; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocio, Spanish National Research Council, University of Seville, Avda. Manuel Siurot s/n, 41013, Seville, Spain. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jul; Vol. 27 (7), pp. 1058-1060. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Letter
MeSH Terms :
Drug Utilization*
SARS-CoV-2*
Anti-Bacterial Agents/*administration & dosage
COVID-19/*epidemiology
Cross-Sectional Studies ; Humans ; Primary Health Care ; Spain/epidemiology ; Time Factors
Opinia redakcyjna
Tytuł :
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
Autorzy :
Sulis G; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Batomen B; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Kotwani A; Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Pai M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Gandra S; Division of Infectious Diseases, Department of Medicine, Washington University in St. Louis, Saint Louis, Missouri, United States of America.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2021 Jul 01; Vol. 18 (7), pp. e1003682. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
SARS-CoV-2*
Anti-Bacterial Agents/*economics
COVID-19/*drug therapy
Drug Utilization/*statistics & numerical data
Hydroxychloroquine/*economics
Pandemics/*economics
Anti-Bacterial Agents/supply & distribution ; Anti-Bacterial Agents/therapeutic use ; COVID-19/economics ; Commerce/statistics & numerical data ; Drug Compounding ; Drug Utilization/economics ; Humans ; Hydroxychloroquine/supply & distribution ; Hydroxychloroquine/therapeutic use ; India ; Interrupted Time Series Analysis ; Pandemics/statistics & numerical data
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Prevalence and risk factors for antibiotic utilization in Chinese children.
Autorzy :
Guo S; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Sun Q; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Zhao X; School of Nursing, China Medical University, Shenyang, 110100, China.
Shen L; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Zhen X; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. .; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China. .
Pokaż więcej
Źródło :
BMC pediatrics [BMC Pediatr] 2021 Jun 01; Vol. 21 (1), pp. 255. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Child ; China/epidemiology ; Drug Resistance, Microbial ; Humans ; Prevalence ; Risk Factors
Czasopismo naukowe
Tytuł :
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Autorzy :
Watanabe JH; Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine.
Kwon J; Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine.
Nan B; Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine.
Abeles SR; Antimicrobial Stewardship, Infection Prevention and Clinical Epidemiology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla.
Jia S; Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine.
Mehta SR; Infectious Disease Section, VA San Diego Clinical Microbiology Laboratory, VA San Diego, La Jolla, California.; Department of Medicine, UC San Diego School of Medicine, La Jolla, California.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 May 03; Vol. 4 (5), pp. e2110775. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Utilization Review*
COVID-19/*drug therapy
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Adult ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Anticoagulants/therapeutic use ; Antiviral Agents/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/epidemiology ; California/epidemiology ; Colchicine/therapeutic use ; Dexamethasone/therapeutic use ; Drug Therapy, Combination ; Female ; Hospitalization ; Humans ; Hydrocortisone/therapeutic use ; Hydroxychloroquine/therapeutic use ; Male ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
Autorzy :
Jang A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Nakashima L; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Ng T; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Fung M; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jiwani S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Schaff K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Suess J; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Goncalves R; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jang D; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Kuik K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Labelle S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pow A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Apr; Vol. 27 (3), pp. 635-643. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Multicenter Study; Pragmatic Clinical Trial
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Cost Savings/*statistics & numerical data
Drug Costs/*statistics & numerical data
Drug Utilization Review/*statistics & numerical data
Antibodies, Monoclonal, Humanized/economics ; Antineoplastic Agents, Immunological/economics ; British Columbia/epidemiology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/economics ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Cost Savings/methods ; Cost-Benefit Analysis/methods ; Cost-Benefit Analysis/statistics & numerical data ; Dose-Response Relationship, Drug ; Drug Utilization Review/economics ; Drug Utilization Review/methods ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/economics ; Lung Neoplasms/epidemiology ; Male ; Melanoma/drug therapy ; Melanoma/economics ; Melanoma/epidemiology ; Retrospective Studies ; Skin Neoplasms/drug therapy ; Skin Neoplasms/economics ; Skin Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban-A European comparative drug utilization study.
Autorzy :
Rottenkolber M; Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universitaet Muenchen, Munich, Germany.
Schmiedl S; Philipp Klee-Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany.; Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
Ibánez L; Fundació Institut Català de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Sabaté M; Fundació Institut Català de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Ballarín E; Fundació Institut Català de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Vidal X; Fundació Institut Català de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Leon-Muñoz LM; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Huerta C; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Martin Merino E; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Montero D; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Gasse C; Department for Depression and Anxiety/Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark.
Andersen M; Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Aakjaer M; Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
De Bruin ML; Copenhagen Centre of Regulatory Science (CORS), Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Gerlach R; National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany.
Tauscher M; National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany.
Souverein PC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
van den Ham R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Klungel O; Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Corporate Authors :
PE&PV consortium
Źródło :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 Mar; Vol. 128 (3), pp. 440-454. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Drug Utilization*
Anticoagulants/*therapeutic use
Dabigatran/*therapeutic use
Pyrazoles/*therapeutic use
Pyridones/*therapeutic use
Rivaroxaban/*therapeutic use
Contraindications, Drug ; Dabigatran/adverse effects ; Drug Interactions ; Drug Prescriptions ; Humans ; Pyrazoles/adverse effects ; Pyridones/adverse effects ; Rivaroxaban/adverse effects
Czasopismo naukowe
Tytuł :
Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016.
Autorzy :
Gradl G; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Teichert M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Kieble M; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Werning J; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Schulz M; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.; Department of Medicine, ABDA-Federal Union of German Associations of Pharmacists, Berlin, DE, Germany.; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, DE, Germany.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2018 Dec; Vol. 27 (12), pp. 1344-1355. Date of Electronic Publication: 2018 Sep 28.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Utilization Review*
Ambulatory Care/*statistics & numerical data
Anti-Bacterial Agents/*administration & dosage
Drug Utilization/*statistics & numerical data
Administration, Oral ; Adolescent ; Age Factors ; Ambulatory Care/trends ; Child ; Child, Preschool ; Databases, Factual/statistics & numerical data ; Drug Prescriptions/standards ; Drug Prescriptions/statistics & numerical data ; Drug Utilization/standards ; Drug Utilization/trends ; Germany ; Humans ; Infant ; Infant, Newborn ; Longitudinal Studies ; Netherlands ; Pharmacies/statistics & numerical data ; Practice Guidelines as Topic
Czasopismo naukowe
Tytuł :
Antibiotic stewardship in the PICU: Impact of ward rounds led by paediatric infectious diseases specialists on antibiotic consumption.
Autorzy :
Renk H; University Children's Hospital Tübingen, Dept. of Paediatric Cardiology, Pulmology and Intensive Care Medicine, Hoppe-Seyler Str. 1, 72076, Tübingen, Germany. .
Sarmisak E; Department of Pharmacy, University Hospital Tübingen, Röntgenweg 9, 72076, Tübingen, Germany.
Spott C; IT Project Management and Medical Controlling, University Hospital Tübingen, Geissweg 3, 72076, Tübingen, Germany.
Kumpf M; University Children's Hospital Tübingen, Dept. of Paediatric Cardiology, Pulmology and Intensive Care Medicine, Hoppe-Seyler Str. 1, 72076, Tübingen, Germany.
Hofbeck M; University Children's Hospital Tübingen, Dept. of Paediatric Cardiology, Pulmology and Intensive Care Medicine, Hoppe-Seyler Str. 1, 72076, Tübingen, Germany.
Hölzl F; Institute for Medical Microbiology and Hygiene, University Hospital Tübingen, Elfriede-Aulhorn-Straße 6, 72076, Tübingen, Germany.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jun 01; Vol. 10 (1), pp. 8826. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Infectious Disease Medicine*
Teaching Rounds*
Anti-Bacterial Agents/*therapeutic use
Antimicrobial Stewardship/*organization & administration
Drug Utilization Review/*organization & administration
Intensive Care Units, Pediatric/*statistics & numerical data
Anti-Bacterial Agents/economics ; Child ; Child, Preschool ; Costs and Cost Analysis ; Drug Utilization ; Female ; Germany ; Hospital Mortality ; Humans ; Inappropriate Prescribing/prevention & control ; Inappropriate Prescribing/statistics & numerical data ; Infant ; Infant, Newborn ; Infections/drug therapy ; Infections/mortality ; Interdisciplinary Communication ; Length of Stay/statistics & numerical data ; Male ; Medical Audit ; Prospective Studies
Czasopismo naukowe
Tytuł :
Preoperative patient education and patient preparedness are associated with less postoperative use of opioids.
Autorzy :
Khorfan R; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Shallcross ML; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Yu B; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Sanchez N; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Parilla S; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Coughlin JM; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL; Department of Surgery, Rush University Medical Center, Chicago, IL.
Johnson JK; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL.
Bilimoria KY; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL; Department of Surgery, Northwestern Memorial Hospital, Chicago, IL.
Stulberg JJ; Surgical Outcomes and Quality Improvement Center, Department of Surgery and Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL; Department of Surgery, Northwestern Memorial Hospital, Chicago, IL. Electronic address: .
Pokaż więcej
Źródło :
Surgery [Surgery] 2020 May; Vol. 167 (5), pp. 852-858. Date of Electronic Publication: 2020 Feb 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Patient Education as Topic*
Postoperative Care*/methods
Preoperative Care*/methods
Analgesics, Opioid/*administration & dosage
Drug Utilization/*statistics & numerical data
Drug Utilization Review ; Humans ; Pain Management ; Pain, Postoperative/drug therapy ; Pain, Postoperative/epidemiology ; Pain, Postoperative/etiology ; Practice Patterns, Physicians'
Czasopismo naukowe
Tytuł :
Drug-utilisation profiles and COVID-19.
Autorzy :
Orlando V; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .
Coscioni E; Division of Cardiac Surgery, AOU San Giovanni di Dio E Ruggi d'Aragona, 84131, Salerno, Italy.
Guarino I; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.
Mucherino S; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.
Perrella A; Infectious Disease of Healthcare Direction, AORN Antonio Cardarelli, 80131, Naples, Italy.
Trama U; Regional Pharmaceutical Unit, Campania Region, 80143, Naples, Italy.
Limongelli G; Department of Translational Medical Science, University of Campania Luigi Vanvitelli, Monaldi Hospital, 80131, Naples, Italy.
Menditto E; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Apr 26; Vol. 11 (1), pp. 8913. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Utilization Review*
COVID-19/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; COVID-19/epidemiology ; COVID-19/virology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Italy/epidemiology ; Male ; Middle Aged ; Renin-Angiotensin System/drug effects ; SARS-CoV-2/isolation & purification ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies